The Market Reports

Index

1 PEGylated Proteins Market Overview
1.1 Product Overview and Scope of PEGylated Proteins
1.2 PEGylated Proteins Segment by Type
1.2.1 Global PEGylated Proteins Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Colony Stimulating Factors
1.2.3 Interferons
1.2.4 Erythropoietin (EPO)
1.2.5 Recombinant Factor VIII
1.2.6 Monoclonal Antibodies
1.2.7 Others
1.3 PEGylated Proteins Segment by Application
1.3.1 Global PEGylated Proteins Sales Comparison by Application: (2021-2027)
1.3.2 Cancer Treatment
1.3.3 Hepatitis
1.3.4 Chronic Kidney Disease
1.3.5 Leukemia
1.3.6 SCID
1.3.7 Rheumatoid Arthritis & Crohn's Disease
1.3.8 Others
1.4 Global PEGylated Proteins Market Size Estimates and Forecasts
1.4.1 Global PEGylated Proteins Revenue 2016-2027
1.4.2 Global PEGylated Proteins Sales 2016-2027

2 PEGylated Proteins Market Competition by Manufacturers
2.1 Global PEGylated Proteins Sales Market Share by Manufacturers (2016-2021)
2.2 Global PEGylated Proteins Revenue Market Share by Manufacturers (2016-2021)
2.3 Global PEGylated Proteins Average Price by Manufacturers (2016-2021)
2.4 Manufacturers PEGylated Proteins Manufacturing Sites, Area Served, Product Type
2.5 PEGylated Proteins Market Competitive Situation and Trends
2.5.1 PEGylated Proteins Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest PEGylated Proteins Players Market Share by Revenue
2.5.3 Global PEGylated Proteins Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 PEGylated Proteins Retrospective Market Scenario by Region
3.1 Global PEGylated Proteins Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global PEGylated Proteins Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America PEGylated Proteins Market Facts & Figures by Country
3.3.1 North America PEGylated Proteins Sales by Country
3.3.2 North America PEGylated Proteins Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe PEGylated Proteins Market Facts & Figures by Country
3.4.1 Europe PEGylated Proteins Sales by Country
3.4.2 Europe PEGylated Proteins Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific PEGylated Proteins Market Facts & Figures by Region
3.5.1 Asia Pacific PEGylated Proteins Sales by Region
3.5.2 Asia Pacific PEGylated Proteins Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America PEGylated Proteins Market Facts & Figures by Country
3.6.1 Latin America PEGylated Proteins Sales by Country
3.6.2 Latin America PEGylated Proteins Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa PEGylated Proteins Market Facts & Figures by Country
3.7.1 Middle East and Africa PEGylated Proteins Sales by Country
3.7.2 Middle East and Africa PEGylated Proteins Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global PEGylated Proteins Historic Market Analysis by Type
4.1 Global PEGylated Proteins Sales Market Share by Type (2016-2021)
4.2 Global PEGylated Proteins Revenue Market Share by Type (2016-2021)
4.3 Global PEGylated Proteins Price by Type (2016-2021)

5 Global PEGylated Proteins Historic Market Analysis by Application
5.1 Global PEGylated Proteins Sales Market Share by Application (2016-2021)
5.2 Global PEGylated Proteins Revenue Market Share by Application (2016-2021)
5.3 Global PEGylated Proteins Price by Application (2016-2021)

6 Key Companies Profiled
6.1 ENZON Pharmaceuticals
6.1.1 ENZON Pharmaceuticals Corporation Information
6.1.2 ENZON Pharmaceuticals Description and Business Overview
6.1.3 ENZON Pharmaceuticals PEGylated Proteins Sales, Revenue and Gross Margin (2016-2021)
6.1.4 ENZON Pharmaceuticals PEGylated Proteins Product Portfolio
6.1.5 ENZON Pharmaceuticals Recent Developments/Updates
6.2 Merck Sharp & Dohme
6.2.1 Merck Sharp & Dohme Corporation Information
6.2.2 Merck Sharp & Dohme Description and Business Overview
6.2.3 Merck Sharp & Dohme PEGylated Proteins Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Merck Sharp & Dohme PEGylated Proteins Product Portfolio
6.2.5 Merck Sharp & Dohme Recent Developments/Updates
6.3 Roche
6.3.1 Roche Corporation Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche PEGylated Proteins Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Roche PEGylated Proteins Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer PEGylated Proteins Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Pfizer PEGylated Proteins Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Amgen
6.5.1 Amgen Corporation Information
6.5.2 Amgen Description and Business Overview
6.5.3 Amgen PEGylated Proteins Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Amgen PEGylated Proteins Product Portfolio
6.5.5 Amgen Recent Developments/Updates
6.6 UCB
6.6.1 UCB Corporation Information
6.6.2 UCB Description and Business Overview
6.6.3 UCB PEGylated Proteins Sales, Revenue and Gross Margin (2016-2021)
6.6.4 UCB PEGylated Proteins Product Portfolio
6.6.5 UCB Recent Developments/Updates
6.7 Crealta (Savient)
6.6.1 Crealta (Savient) Corporation Information
6.6.2 Crealta (Savient) Description and Business Overview
6.6.3 Crealta (Savient) PEGylated Proteins Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Crealta (Savient) PEGylated Proteins Product Portfolio
6.7.5 Crealta (Savient) Recent Developments/Updates

7 PEGylated Proteins Manufacturing Cost Analysis
7.1 PEGylated Proteins Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of PEGylated Proteins
7.4 PEGylated Proteins Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 PEGylated Proteins Distributors List
8.3 PEGylated Proteins Customers

9 PEGylated Proteins Market Dynamics
9.1 PEGylated Proteins Industry Trends
9.2 PEGylated Proteins Growth Drivers
9.3 PEGylated Proteins Market Challenges
9.4 PEGylated Proteins Market Restraints

10 Global Market Forecast
10.1 PEGylated Proteins Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of PEGylated Proteins by Type (2022-2027)
10.1.2 Global Forecasted Revenue of PEGylated Proteins by Type (2022-2027)
10.2 PEGylated Proteins Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of PEGylated Proteins by Application (2022-2027)
10.2.2 Global Forecasted Revenue of PEGylated Proteins by Application (2022-2027)
10.3 PEGylated Proteins Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of PEGylated Proteins by Region (2022-2027)
10.3.2 Global Forecasted Revenue of PEGylated Proteins by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global PEGylated Proteins Sales (g) Growth Rate Comparison by Type (2021-2027)
Table 2. Global PEGylated Proteins Sales (g) Comparison by Application (2021-2027)
Table 3. Global PEGylated Proteins Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers PEGylated Proteins Covered in This Study
Table 5. Global PEGylated Proteins Sales (g) of Key Manufacturers (2016-2021)
Table 6. Global PEGylated Proteins Sales Market Share by Manufacturers (2016-2021)
Table 7. Global PEGylated Proteins Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global PEGylated Proteins Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market PEGylated Proteins Average Price (US$/mg) of Key Manufacturers (2016-2021)
Table 10. Manufacturers PEGylated Proteins Manufacturing Sites and Area Served
Table 11. Manufacturers PEGylated Proteins Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global PEGylated Proteins by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PEGylated Proteins as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global PEGylated Proteins Sales by Region (2016-2021) & (g)
Table 16. Global PEGylated Proteins Sales Market Share by Region (2016-2021)
Table 17. Global PEGylated Proteins Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America PEGylated Proteins Sales by Country (2016-2021) & (g)
Table 19. North America PEGylated Proteins Sales Market Share by Country (2016-2021)
Table 20. North America PEGylated Proteins Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America PEGylated Proteins Revenue Market Share by Country (2016-2021)
Table 22. Europe PEGylated Proteins Sales by Country (2016-2021) & (g)
Table 23. Europe PEGylated Proteins Sales Market Share by Country (2016-2021)
Table 24. Europe PEGylated Proteins Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe PEGylated Proteins Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific PEGylated Proteins Sales by Region (2016-2021) & (g)
Table 27. Asia Pacific PEGylated Proteins Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific PEGylated Proteins Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific PEGylated Proteins Revenue Market Share by Region (2016-2021)
Table 30. Latin America PEGylated Proteins Sales by Country (2016-2021) & (g)
Table 31. Latin America PEGylated Proteins Sales Market Share by Country (2016-2021)
Table 32. Latin America PEGylated Proteins Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America PEGylated Proteins Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa PEGylated Proteins Sales by Country (2016-2021) & (g)
Table 35. Middle East and Africa PEGylated Proteins Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa PEGylated Proteins Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa PEGylated Proteins Revenue Market Share by Country (2016-2021)
Table 38. Global PEGylated Proteins Sales (g) by Type (2016-2021)
Table 39. Global PEGylated Proteins Sales Market Share by Type (2016-2021)
Table 40. Global PEGylated Proteins Revenue (Million US$) by Type (2016-2021)
Table 41. Global PEGylated Proteins Revenue Share by Type (2016-2021)
Table 42. Global PEGylated Proteins Price (US$/mg) by Type (2016-2021)
Table 43. Global PEGylated Proteins Sales (g) by Application (2016-2021)
Table 44. Global PEGylated Proteins Sales Market Share by Application (2016-2021)
Table 45. Global PEGylated Proteins Revenue (Million US$) by Application (2016-2021)
Table 46. Global PEGylated Proteins Revenue Share by Application (2016-2021)
Table 47. Global PEGylated Proteins Price (US$/mg) by Application (2016-2021)
Table 48. ENZON Pharmaceuticals Corporation Information
Table 49. ENZON Pharmaceuticals Description and Business Overview
Table 50. ENZON Pharmaceuticals PEGylated Proteins Sales (g), Revenue (Million US$), Price (US$/mg) and Gross Margin (2016-2021)
Table 51. ENZON Pharmaceuticals PEGylated Proteins Product
Table 52. ENZON Pharmaceuticals Recent Developments/Updates
Table 53. Merck Sharp & Dohme Corporation Information
Table 54. Merck Sharp & Dohme Description and Business Overview
Table 55. Merck Sharp & Dohme PEGylated Proteins Sales (g), Revenue (Million US$), Price (US$/mg) and Gross Margin (2016-2021)
Table 56. Merck Sharp & Dohme PEGylated Proteins Product
Table 57. Merck Sharp & Dohme Recent Developments/Updates
Table 58. Roche Corporation Information
Table 59. Roche Description and Business Overview
Table 60. Roche PEGylated Proteins Sales (g), Revenue (Million US$), Price (US$/mg) and Gross Margin (2016-2021)
Table 61. Roche PEGylated Proteins Product
Table 62. Roche Recent Developments/Updates
Table 63. Pfizer Corporation Information
Table 64. Pfizer Description and Business Overview
Table 65. Pfizer PEGylated Proteins Sales (g), Revenue (Million US$), Price (US$/mg) and Gross Margin (2016-2021)
Table 66. Pfizer PEGylated Proteins Product
Table 67. Pfizer Recent Developments/Updates
Table 68. Amgen Corporation Information
Table 69. Amgen Description and Business Overview
Table 70. Amgen PEGylated Proteins Sales (g), Revenue (Million US$), Price (US$/mg) and Gross Margin (2016-2021)
Table 71. Amgen PEGylated Proteins Product
Table 72. Amgen Recent Developments/Updates
Table 73. UCB Corporation Information
Table 74. UCB Description and Business Overview
Table 75. UCB PEGylated Proteins Sales (g), Revenue (Million US$), Price (US$/mg) and Gross Margin (2016-2021)
Table 76. UCB PEGylated Proteins Product
Table 77. UCB Recent Developments/Updates
Table 78. Crealta (Savient) Corporation Information
Table 79. Crealta (Savient) Description and Business Overview
Table 80. Crealta (Savient) PEGylated Proteins Sales (g), Revenue (Million US$), Price (US$/mg) and Gross Margin (2016-2021)
Table 81. Crealta (Savient) PEGylated Proteins Product
Table 82. Crealta (Savient) Recent Developments/Updates
Table 83. Production Base and Market Concentration Rate of Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. PEGylated Proteins Distributors List
Table 86. PEGylated Proteins Customers List
Table 87. PEGylated Proteins Market Trends
Table 88. PEGylated Proteins Growth Drivers
Table 89. PEGylated Proteins Market Challenges
Table 90. PEGylated Proteins Market Restraints
Table 91. Global PEGylated Proteins Sales Forecast by Type (2022-2027) & (g)
Table 92. Global PEGylated Proteins Sales Market Share Forecast by Type (2022-2027)
Table 93. Global PEGylated Proteins Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 94. Global PEGylated Proteins Revenue Market Share Forecast by Type (2022-2027)
Table 95. Global PEGylated Proteins Sales Forecast by Application (2022-2027) & (g)
Table 96. Global PEGylated Proteins Sales Market Share Forecast by Application (2022-2027)
Table 97. Global PEGylated Proteins Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 98. Global PEGylated Proteins Revenue Market Share Forecast by Application (2022-2027)
Table 99. Global PEGylated Proteins Sales Forecast by Region (2022-2027) & (g)
Table 100. Global PEGylated Proteins Sales Market Share Forecast by Region (2022-2027)
Table 101. Global PEGylated Proteins Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 102. Global PEGylated Proteins Revenue Market Share Forecast by Region (2022-2027)
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of PEGylated Proteins
Figure 2. Global PEGylated Proteins Market Share by Type in 2020 & 2027
Figure 3. Colony Stimulating Factors Product Picture
Figure 4. Interferons Product Picture
Figure 5. Erythropoietin (EPO) Product Picture
Figure 6. Recombinant Factor VIII Product Picture
Figure 7. Monoclonal Antibodies Product Picture
Figure 8. Others Product Picture
Figure 9. Global PEGylated Proteins Market Share by Application in 2020 & 2027
Figure 10. Cancer Treatment
Figure 11. Hepatitis
Figure 12. Chronic Kidney Disease
Figure 13. Leukemia
Figure 14. SCID
Figure 15. Rheumatoid Arthritis & Crohn's Disease
Figure 16. Others
Figure 17. Global PEGylated Proteins Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global PEGylated Proteins Market Size 2016-2027 (US$ Million)
Figure 19. Global PEGylated Proteins Sales 2016-2027 (g)
Figure 20. Global PEGylated Proteins Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 21. PEGylated Proteins Sales Share by Manufacturers in 2020
Figure 22. Global PEGylated Proteins Revenue Share by Manufacturers in 2020
Figure 23. The Global 5 and 10 Largest PEGylated Proteins Players: Market Share by Revenue in 2020
Figure 24. PEGylated Proteins Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 25. Global PEGylated Proteins Sales Market Share by Region (2016-2021)
Figure 26. Global PEGylated Proteins Sales Market Share by Region in 2020
Figure 27. Global PEGylated Proteins Revenue Market Share by Region (2016-2021)
Figure 28. Global PEGylated Proteins Revenue Market Share by Region in 2020
Figure 29. U.S. PEGylated Proteins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Canada PEGylated Proteins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Germany PEGylated Proteins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. France PEGylated Proteins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. U.K. PEGylated Proteins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Italy PEGylated Proteins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Russia PEGylated Proteins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. China PEGylated Proteins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Japan PEGylated Proteins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. South Korea PEGylated Proteins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. India PEGylated Proteins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Australia PEGylated Proteins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. China Taiwan PEGylated Proteins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Indonesia PEGylated Proteins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Thailand PEGylated Proteins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Malaysia PEGylated Proteins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Mexico PEGylated Proteins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Brazil PEGylated Proteins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Argentina PEGylated Proteins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Turkey PEGylated Proteins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Saudi Arabia PEGylated Proteins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. UAE PEGylated Proteins Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. Sales Market Share of PEGylated Proteins by Type (2016-2021)
Figure 52. Sales Market Share of PEGylated Proteins by Application (2016-2021)
Figure 53. Sales Market Share of PEGylated Proteins by Application in 2020
Figure 54. Revenue Share of PEGylated Proteins by Application (2016-2021)
Figure 55. Revenue Share of PEGylated Proteins by Application in 2020
Figure 56. Manufacturing Cost Structure of PEGylated Proteins
Figure 57. Manufacturing Process Analysis of PEGylated Proteins
Figure 58. PEGylated Proteins Industrial Chain Analysis
Figure 59. Channels of Distribution
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed